. . "P\u0159i studiu klonality pomoc\u00ED XCIP eseje u 29 \u017Een s MDS byla nalezena p\u0159\u00EDtomnost klon\u00E1ln\u00EDch subpopulac\u00ED granulocyt\u016F a CD14+ monocyt\u016F v perifern\u00ED krvi a kostn\u00ED d\u0159eni u 11 z 12 nemocn\u00FDch s RCMD a pouze u 1 ze 7 nemocn\u00FDch s RA \u010Di RARS. Pr\u016Fm\u011Brn\u00E1 doba p\u0159e\u017Eit\u00ED nemocn\u00FDch bez zn\u00E1mek klon\u00E1ln\u00ED krvetvorby byla 89,8 m\u011Bs\u00EDce oproti 33,2 m\u011Bs\u00EDce u nemocn\u00FDch s klon\u00E1ln\u00ED krvetvorbou. N\u00E1lezy mohou podporovat teorii v\u00EDcestup\u0148ov\u00E9 patogeneze MDS, kdy dysplasie omezen\u00E1 na \u010Dervenou \u0159adu m\u016F\u017Ee p\u0159edstavovat \u010Dasn\u00FD stupe\u0148 a dysplasieve v\u00EDce \u0159ad\u00E1ch n\u00E1sledn\u00FD stupe\u0148 rozv\u00EDjej\u00EDc\u00ED se klon\u00E1ln\u00ED poruchy." . "RIV/00023736:_____/04:I0000111!RIV/2005/MZ0/L33005/N" . . "2004-06-02+02:00"^^ . . . "Sieglov\u00E1, Zuzana" . "XVIII. olomouck\u00E9 hematologick\u00E9 dny s mezin\u00E1rodn\u00ED \u00FA\u010Dast\u00ED" . . . "Michalov\u00E1, Kyra" . "29" . "clonality;myelodysplastic syndrome;pathogenesis;prognosis"@en . "Olomouc" . . "Olomouc" . "Significant clonality treatment in patients with MDS."@en . . "4"^^ . "Significant clonality treatment in patients with MDS."@en . "V\u00FDznam vy\u0161et\u0159en\u00ED klonality u nemocn\u00FDch s myelodysplastick\u00FDm syndromem." . "1"^^ . . "RIV/00023736:_____/04:I0000111" . . . . . . . . "Clonal patterns ot hematopoiesis were studied using XCIP assay in 29 females with MDS. Clonal supopulations of granulocytes and CD14+ monocytes were present in 11 out of 12 patients with RCMD in contrast to only 1 out of 7 patients with RA or RARS. Median survival of patients without clonal cells was 89,8 months compared with 33,2 months in those with clonal cell subpopulations. The results support hypothesis of a multistep pathogenesis of MDS, when dysplasia limited to erythopoiesis may represents anearly step an multilineage dysplasia a consequent step reflecting progression of clonal disorder."@en . "Krej\u010Dov\u00E1, H." . "Rubico" . "V\u00FDznam vy\u0161et\u0159en\u00ED klonality u nemocn\u00FDch s myelodysplastick\u00FDm syndromem."@cs . "80-7346-023-8" . . . "V\u00FDznam vy\u0161et\u0159en\u00ED klonality u nemocn\u00FDch s myelodysplastick\u00FDm syndromem."@cs . "V\u00FDznam vy\u0161et\u0159en\u00ED klonality u nemocn\u00FDch s myelodysplastick\u00FDm syndromem." . . "5"^^ . "594825" . "P(NK7713), Z(MZ00237360001)" . . "Lerm\u00E1k, Jaroslav" . "P\u0159i studiu klonality pomoc\u00ED XCIP eseje u 29 \u017Een s MDS byla nalezena p\u0159\u00EDtomnost klon\u00E1ln\u00EDch subpopulac\u00ED granulocyt\u016F a CD14+ monocyt\u016F v perifern\u00ED krvi a kostn\u00ED d\u0159eni u 11 z 12 nemocn\u00FDch s RCMD a pouze u 1 ze 7 nemocn\u00FDch s RA \u010Di RARS. Pr\u016Fm\u011Brn\u00E1 doba p\u0159e\u017Eit\u00ED nemocn\u00FDch bez zn\u00E1mek klon\u00E1ln\u00ED krvetvorby byla 89,8 m\u011Bs\u00EDce oproti 33,2 m\u011Bs\u00EDce u nemocn\u00FDch s klon\u00E1ln\u00ED krvetvorbou. N\u00E1lezy mohou podporovat teorii v\u00EDcestup\u0148ov\u00E9 patogeneze MDS, kdy dysplasie omezen\u00E1 na \u010Dervenou \u0159adu m\u016F\u017Ee p\u0159edstavovat \u010Dasn\u00FD stupe\u0148 a dysplasieve v\u00EDce \u0159ad\u00E1ch n\u00E1sledn\u00FD stupe\u0148 rozv\u00EDjej\u00EDc\u00ED se klon\u00E1ln\u00ED poruchy."@cs . "[A0E77AC5FB68]" . "Beli\u010Dkov\u00E1, Monika" . .